As of 2025-12-16, the Relative Valuation of Rain Therapeutics Inc (RAIN) is (13.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.04 USD, the upside of Rain Therapeutics Inc based on Relative Valuation is -330.6%.
The range of the Relative Valuation is (13.99) - (14.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 20.2x | 19.2x |
| Forward P/E multiples | 19.7x - 20.4x | 20.1x |
| Fair Price | (13.99) - (14.30) | (13.93) |
| Upside | -331.7% - -336.8% | -330.6% |
| Date | P/E |
| 2025-12-15 | -9.31 |
| 2025-12-12 | -8.73 |
| 2025-12-11 | -8.83 |
| 2025-12-10 | -8.63 |
| 2025-12-09 | -7.84 |
| 2025-12-08 | -7.72 |
| 2025-12-05 | -7.70 |
| 2025-12-04 | -8.20 |
| 2025-12-03 | -7.62 |
| 2025-12-02 | -7.32 |
| 2025-12-01 | -7.67 |
| 2025-11-28 | -7.62 |
| 2025-11-26 | -7.49 |
| 2025-11-25 | -7.82 |
| 2025-11-24 | -6.83 |
| 2025-11-21 | -6.76 |
| 2025-11-20 | -6.36 |
| 2025-11-19 | -6.39 |
| 2025-11-18 | -6.29 |
| 2025-11-17 | -7.63 |
| 2025-11-14 | -8.75 |
| 2025-11-13 | -7.86 |
| 2025-11-12 | -7.41 |
| 2025-11-11 | -7.67 |
| 2025-11-10 | -6.96 |
| 2025-11-07 | -7.15 |
| 2025-11-06 | -7.04 |
| 2025-11-05 | -7.18 |
| 2025-11-04 | -7.19 |
| 2025-11-03 | -7.53 |
| 2025-10-31 | -7.42 |
| 2025-10-30 | -8.16 |
| 2025-10-29 | -8.36 |
| 2025-10-28 | -8.46 |
| 2025-10-27 | -8.21 |
| 2025-10-24 | -8.34 |
| 2025-10-23 | -8.21 |
| 2025-10-22 | -8.46 |
| 2025-10-21 | -7.69 |
| 2025-10-20 | -7.97 |
| 2025-10-17 | -7.01 |
| 2025-10-16 | -7.07 |
| 2025-10-15 | -7.28 |
| 2025-10-14 | -6.70 |
| 2025-10-13 | -6.77 |
| 2025-10-10 | -6.77 |
| 2025-10-09 | -7.79 |
| 2025-10-08 | -7.27 |
| 2025-10-07 | -7.18 |
| 2025-10-06 | -6.91 |